Global Cryoablation Devices Market Report and Forecast 2024-2032

Global Cryoablation Devices Market Report and Forecast 2024-2032


Global Cryoablation Devices Market Outlook

The global cryoablation devices market size was valued at USD 457.7 million in 2023, driven by the increasing demand for minimally invasive treatments for various medical conditions, particularly cancers and cardiac arrhythmias across the globe. The market size is anticipated to grow at a CAGR of 10.3% during the forecast period of 2024-2032 to achieve a value of USD 1106 million by 2032.

Cryoablation Devices: Introduction

Cryoablation devices are medical instruments used in cryoablation therapy, a minimally invasive treatment that employs extreme cold to destroy abnormal tissues, including cancer cells. These devices function by delivering liquid nitrogen or argon gas through a probe, creating intensely cold temperatures that freeze and subsequently destroy the targeted cells. Cryoablation is commonly used in the treatment of various types of tumours, such as those in the liver, kidney, and breast, and is also employed in the treatment of certain cardiac arrhythmias like atrial fibrillation.

The appeal of cryoablation lies in its minimally invasive nature, which often results in shorter recovery times and fewer complications compared to traditional surgical methods. Additionally, it allows for precise targeting of diseased tissues while sparing the surrounding healthy areas. Cryoablation devices have become increasingly sophisticated, offering improved control and safety during procedures, making them valuable tools in the arsenal of modern medical treatments.

Key Trends in the Global Cryoablation Devices Market

The global cryoablation devices market is witnessing several key trends that are shaping its growth and evolution. Firstly, technological advancements are at the forefront, with newer devices offering enhanced precision, safety, and efficacy in targeting abnormal tissues. There's a notable shift towards devices that are more user-friendly and that provide real-time feedback during procedures. Another significant trend is the increasing adoption of cryoablation for the treatment of various cancers and cardiac conditions, driven by a growing body of clinical evidence supporting its effectiveness and safety. This is coupled with the rising global incidence of cancer and cardiac diseases, which fuels demand for minimally invasive and effective treatment options. The integration of cryoablation with imaging technologies like ultrasound and MRI is also gaining traction, facilitating more accurate targeting and monitoring of the ablation process.

Furthermore, there is an expanding focus on training and education for healthcare professionals to effectively use these devices. Lastly, regulatory approvals and collaborations among key players in the market are paving the way for the introduction of innovative cryoablation solutions across various regions. Collectively, these trends underscore a dynamic and expanding market, driven by technological innovation and the increasing acceptance of cryoablation as a therapeutic modality.

Global Cryoablation Devices Market Segmentation

Market Breakup by Type
  • Tissue Contact Probe Ablators
  • Epidermal and Subcutaneous Cryoablation Systems
  • Tissue Spray Probe Ablators
Market Breakup by Applications
  • Prostate Cancer
  • Renal Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Cardiac Arrhythmia
Market Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Cryoablation Devices Market Overview

The global cryoablation devices market is a significant and growing segment within the medical devices industry, driven by the increasing demand for minimally invasive treatments for various medical conditions, particularly cancers and cardiac arrhythmias. This market benefits from technological advancements that have led to the development of more sophisticated, precise, and safer cryoablation devices. These innovations allow for targeted destruction of abnormal tissues while minimizing damage to surrounding healthy structures. The growing global incidence of cancer and the rising prevalence of cardiac diseases are key factors fuelling the demand for effective and minimally invasive treatment options, consequently driving the growth of the cryoablation devices market. Moreover, the integration of cryoablation with advanced imaging techniques enhances procedural accuracy and outcomes, further boosting market growth.

The market is also supported by increasing regulatory approvals for new devices and expanding indications for existing ones. Despite these positive drivers, the market faces challenges, such as the need for specialized training for healthcare professionals and high costs associated with the technology. Overall, the global cryoablation devices market is poised for continued expansion, reflecting an ongoing shift in healthcare towards less invasive and more patient-friendly therapeutic options.

Global Cryoablation Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Atricure, INC.
  • Galil Medical INC.
  • Metrum Cryoflex SP
  • BVM Medical Limited
  • Medtronic plc
  • CPSI Biotech
  • CooperSurgical INC.
  • HealthTronics, INC.
  • Icecure Medical
  • Sanarus Technologies
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cryoablation Devices Market Overview
3.1 Global Cryoablation Devices Market Historical Value (2017-2023)
3.2 Global Cryoablation Devices Market Forecast Value (2024-2032)
4 Global Cryoablation Devices Market Landscape
4.1 Global Cryoablation Devices: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cryoablation Devices: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Cryoablation Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cryoablation Devices Market Segmentation
6.1 Global Cryoablation Devices Market by Type
6.1.1 Market Overview
6.1.2 Tissue Contact Probe Ablators
6.1.3 Epidermal and Subcutaneous Cryoablation Systems
6.1.4 Tissue Spray Probe Ablators
6.2 Global Cryoablation Devices Market by Applications
6.2.1 Market Overview
6.2.2 Prostate Cancer
6.2.3 Renal Cancer
6.2.4 Liver Cancer
6.2.5 Breast Cancer
6.2.6 Lung Cancer
6.2.7 Cardiac Arrhythmia
6.3 Global Cryoablation Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Ambulatory Surgical Centres
6.4 Global Cryoablation Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cryoablation Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cryoablation Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cryoablation Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cryoablation Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cryoablation Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Atricure, INC.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 Galil Medical INC.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Metrum Cryoflex SP
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 BVM Medical Limited
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Medtronic plc
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 CPSI Biotech
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 CooperSurgical INC.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 HealthTronics, INC.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Icecure Medical
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Sanarus Technologies
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings